دورية أكاديمية
Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021
| العنوان: | Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021 |
|---|---|
| المؤلفون: | Miele, Kathryn, Kim, Shin Y, Jones, Rachelle, Rembert, Juneka H, Wachman, Elisha M, Shrestha, Hira, Henninger, Michelle L, Kimes, Teresa M, Schneider, Patrick D, Sivaloganathan, Vaseekaran, Sward, Katherine A, Deshmukh, Vikrant G, Sanjuan, Pilar M, Maxwell, Jessie R, Seligman, Neil S, Caveglia, Sarah, Louis, Judette M, Wright, Tanner, Bennett, Carolyne Cody, Green, Caitlin, George, Nisha, Gosdin, Lucas, Tran, Emmy L, Meaney-Delman, Dana, Gilboa, Suzanne M |
| المصدر: | Pediatrics Research and Scholarship |
| بيانات النشر: | UNM Digital Repository |
| سنة النشر: | 2023 |
| المجموعة: | UNM Digital Repository (The University of New Mexico) |
| مصطلحات موضوعية: | Adult, Female, Humans, Infant, Pregnancy, Ethnicity, Family, Hispanic or Latino, Opioid-Related Disorders, Population Surveillance, United States, Pregnancy Outcome, Young Adult, Black or African American, White |
| الوصف: | PROBLEM: Medication for opioid use disorder (MOUD) is recommended for persons with opioid use disorder (OUD) during pregnancy. However, knowledge gaps exist about best practices for management of OUD during pregnancy and these data are needed to guide clinical care. PERIOD COVERED: 2014-2021. DESCRIPTION OF THE SYSTEM: Established in 2019, the Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder During Pregnancy (MAT-LINK) is a surveillance network of seven clinical sites in the United States. Boston Medical Center, Kaiser Permanente Northwest, The Ohio State University, and the University of Utah were the initial clinical sites in 2019. In 2021, three clinical sites were added to the network (the University of New Mexico, the University of Rochester, and the University of South Florida). Persons receiving care at the seven clinical sites are diverse in terms of geography, urbanicity, race and ethnicity, insurance coverage, and type of MOUD received. The goal of MAT-LINK is to capture demographic and clinical information about persons with OUD during pregnancy to better understand the effect of MOUD on outcomes and, ultimately, provide information for clinical care and public health interventions for this population. MAT-LINK maintains strict confidentiality through robust information technology architecture. MAT-LINK surveillance methods, population characteristics, and evaluation findings are described in this inaugural surveillance report. This report is the first to describe the system, presenting detailed information on funding, structure, data elements, and methods as well as findings from a surveillance evaluation. The findings presented in this report are limited to selected demographic characteristics of pregnant persons overall and by MOUD treatment status. Clinical and outcome data are not included because data collection and cleaning have not been completed; initial analyses of clinical and outcome data will begin in 2023. RESULTS: The MAT-LINK ... |
| نوع الوثيقة: | text |
| وصف الملف: | application/pdf |
| اللغة: | unknown |
| العلاقة: | https://digitalrepository.unm.edu/peds_pubs/638Test; https://digitalrepository.unm.edu/context/peds_pubs/article/1634/viewcontent/ss7203a1.pdfTest |
| الإتاحة: | https://digitalrepository.unm.edu/peds_pubs/638Test https://digitalrepository.unm.edu/context/peds_pubs/article/1634/viewcontent/ss7203a1.pdfTest |
| رقم الانضمام: | edsbas.D6881AE2 |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |